Referenslista
1. Fitzpatrick´s Dermatology in General Medicine, Sixth Edition, vol.1.
p. 407-8.
2. Zachariae, H., Prevalence of joint disease in patients with psoriasis: implications for therapy. Am J Clin Dermatol. 2003. 4(7): p.441-7.
3. Schön, MP and WH. Boehncke. Psoriasis. N Engl J Med.
2005 May 5; 352(18): p.1899-912.
4. Mrowietz, U., et al., The importance of disease associations and concomitant therapy for the long-term management of psoriasis patients. Arch Dermatol Res, 2006 Dec. 298(7): p.309-319.
5. Mallbris, L., et al., Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol, 2006 April. 54(4): p.614-621.
6 Ludwig, RJ., et al., Psoriasis: a possible risk factor for development of coronary artery calcification. Br J Dermatol, 2007 Feb. 156(2): p.271-276.
7 Mikels, AJ and R. Nusse., Wnts as ligands: processing, secretion and reception. Oncogene, 2006 Dec. 25(57): p.7461-8.
8 Mikels, AJ and R. Nusse., Wnts as ligands: processing, secretion and reception. Oncogene, 2006 Dec. 25(57): p.7461-8.
9 The, MT., et al., Role for WNT16B in human epidermal keratinocyte proliferation and differentiation. J Cell Sci, 2007 Jan. 120( Pt 2): p.330-9.
10. Christodoulides, C., et al., WNT10B mutations in human obesity. Diabetologia, 2006 Apr. 49(4): p.678-84
11 Fujino, T., et al., Low-density lipoprotein receptor-related protein 5 (LRP5) is essential for normal cholesterol metabolism and glucose-induced insulin secretion. Proc Natl Acad Sci USA, 2003 Jan. 100(1): p.229-34.
12 Yamaguchi, Y., et al., Dickkopf 1 (DKK1) regulates skin pigmentation and thickness by affecting Wnt/{beta}-catenin signaling in keratinocytes.
FASEB J, 2007 Nov.
13 Mani, A., et al., LRP6 Mutation in a family with early coronary disease and metabolic risk factors. Science, 2007 Mar. 315(5816) : p.1278-82.
14 Reischl, J., et al., Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol, 2007 Jan. 127(1): p.163-9.